Ariake Hospital of Japanese Foundation for Cancer Research,Tokyo, Japan.
Surg Endosc. 2011 Mar;25(3):841-8. doi: 10.1007/s00464-010-1279-4. Epub 2010 Aug 24.
Endoscopic ultrasonography (EUS) has become a reliable method for predicting the invasion depth of early gastric cancer (EGC). This study evaluated the accuracy of EUS in identifying lesions meeting expanded-indication criteria for endoscopic submucosal dissection (ESD) and analyzed clinicopathologic factors influencing the diagnostic accuracy of EUS in assessing tumor invasion depth.
This study investigated 542 EGCs of 515 patients who underwent EUS pretreatment. The pretreatment EUS-determined diagnosis was compared with the final histopathologic evaluation of resected specimens, and the impact of various clinicopathologic parameters on diagnostic accuracy was analyzed.
The diagnostic accuracy of EUS in identifying lesions meeting expanded-indication criteria for ESD was 87.8% (259/295) for differentiated adenocarcinoma (D-type) 30 mm in diameter or smaller, 43.5% (10/23) for D-type tumor larger than 30 mm in diameter, and 75% (42/56) for undifferentiated adenocarcinoma (UD-type) 20 mm in diameter or smaller. Using multivariate analysis, the diagnostic accuracy of EUS in predicting tumor invasion depth was determined to be decreased significantly by ulcerous change and large tumor size (diameter, ≥30 mm).
For patients with EGC, D-type lesions 30 mm in diameter or smaller and UD-type lesions 20 mm in diameter or smaller can be diagnosed with high accuracy by EUS, but larger D-type lesions (diameter, >30 mm) should be considered carefully in terms of EUS-based treatment decisions. Findings of ulceration and large tumors are associated with incorrect diagnosis of tumor invasion depth by EUS.
内镜超声检查(EUS)已成为预测早期胃癌(EGC)浸润深度的可靠方法。本研究评估了 EUS 识别符合内镜黏膜下剥离术(ESD)扩大适应证标准的病变的准确性,并分析了影响 EUS 评估肿瘤浸润深度诊断准确性的临床病理因素。
本研究调查了 515 例接受 EUS 术前治疗的 542 例 EGC 患者。将术前 EUS 诊断与切除标本的最终组织病理学评估进行比较,并分析各种临床病理参数对诊断准确性的影响。
EUS 对符合 ESD 扩大适应证标准的病变的诊断准确率为:直径 30mm 或以下的分化型腺癌(D 型)为 87.8%(259/295),直径大于 30mm 的 D 型肿瘤为 43.5%(10/23),直径 20mm 或以下的未分化型腺癌(UD 型)为 75%(42/56)。多因素分析显示,EUS 预测肿瘤浸润深度的诊断准确性因溃疡改变和肿瘤体积大(直径≥30mm)而显著降低。
对于 EGC 患者,直径 30mm 或以下的 D 型病变和直径 20mm 或以下的 UD 型病变可通过 EUS 准确诊断,但对于直径较大的 D 型病变(直径>30mm),应慎重考虑基于 EUS 的治疗决策。溃疡和大肿瘤的存在与 EUS 对肿瘤浸润深度的错误诊断有关。